BSTC Financial Facts

General and administrative: 1.71M
Licensing revenues: 1.01M
See Full Income Statement

Accrued liabilities of discontinued operations: 78.14K
Total current liabilities: 778.58K
See Full Balance Sheet

BioSpecifics Technologies Corp. (BSTC) Earnings

  |   Expand Research on BSTC
Next EPS Date 2/11/16 *Est. EPS Growth Rate +85.7% *Last Qtr.
Average EPS % Beat Rate +28.5% Revenue Growth Rate +57.5% *Last Qtr.
Average % Move 1-Wk after EPS +1.3% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/15 Q315 $0.39N/A N/A $6.3M$7.51M N/A Details
8/10/15 Q215 $0.24N/A N/A $4.7M$2.6M N/A Details
5/11/15 Q414 $0.32N/A N/A $5.6M$2.3M N/A Details
11/10/14 Q314 $0.21$0.19 +$0.02$4M$4M N/A Details
8/11/14 Q214 $0.09$0.12 -$0.03$2.7M$2.91M N/A Details
5/8/14 Q114 $0.12$0.07 +$0.05$2.8M$2.46M N/A Details
8/9/12 Q212 $0.11$0.07 +$0.04$2.6M$2.5M N/A Details
3/9/12 Q411 $0.01N/A N/A $2.6M$1.1M N/A Details